Syngene International Limited has informed the Exchange regarding a press release dated January 19, 2026, titled "Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035".
Syngene International Ltd. Press Release Jan 19 2026
Filed with NSE · · 3 pages · English
Watch Syngene International's latest callSyngene International (NSE:SYNGENE) Q2 2027 Earnings Call · Replay · Oct 28Read the transcript of Syngene International (NSE:SYNGENE) Q2 2027 Earnings CallRelease
Syngene International Ltd. on 6ix
Earlier from Syngene International
- Press Release Nov 05 2025
- Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development
- Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
- Syngene International invests in dedicated peptide laboratory and advanced automation
- Press Release Jul 23 2025
Later from Syngene International
- Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
- Press Release Jan 22 2026
- VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure
- Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
- Press Release Apr 29 2026
Follow Syngene International into a list and get an email when it puts out news.
Follow Syngene International